PCW-A1001, AI-assisted de novo design approach to design a selective inhibitor for FLT-3(D835Y) in acute myeloid leukemia

Overview of attention for article published in Frontiers in Molecular Biosciences, November 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

blogs: 1 blog

twitter: 4 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 5 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 28,575 followers.

New Research: PCW-A1001, AI-assisted de novo design approach to design a selective inhibitor for FLT-3(D835Y) in acute myeloid leukemia https://t.co/aVPYMjx2Tl #MolBioSci

20 Dec 2022

Reply Repost Favourite

If you are interested in learning more about #ai in #drugdiscovery, you can find the paper here: https://t.co/NAd5uxZ2fx Congratulations Suneel; we're excited to have brought this expertise into our group. #compchem #neuralnetwork #artificialintelligence

08 Dec 2022

Reply Repost Favourite

Thank you @biogerontology for sharing the paper and for the appreciation

30 Nov 2022

Reply Repost Favourite

Pretty cool paper by Korea's PharmCADD group and collaborators https://t.co/GuvcPpAcPp

26 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.